Live Breaking News & Updates on Renal Function Affect Treatment

People with type 2 diabetes who tried agents from three different classes of glucose-lowering drugs usually found one they liked most. It was also often their safest and most effective option. ....

United Kingdom , Andrew Hattersley , European Association For The Study Of Diabetes , University Of Exeter , Nature Medicine , European Association , Medscape Medical , Renal Function Affect Treatment , Medscape Medical News , Agent They Liked , Diabetes Mellitus Type 2 , Iabetes Mellitus Type Ii , Type 2 Diabetes , Adverse Effects , Side Effects , Body Mass Index Bmi , Patient Safety , Dpp 4 Inhibitors , Dipeptidyl Peptidase 4 Inhibitors , Sglt2 Inhibitors , Odium Glucose Transporter 2 Inhibitors , Odium Glucose Co Transporter 2 Inhibitors , Sodium Glucose Cotransporter 2 Inhibitors , Physician Patient Decision Making , Atient C ,